Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SLC9A3 | P48764 | 5/20 | 0.40 |
| ▸ | FBP1 | P09467 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 3/20 | 0.35 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25558381 | 0.88 | MAPT (0.41) | SMN1; SMN2NPC1MAPTRAB9ASLC9A3 | |
| SCHEMBL25546414 | 0.88 | KDM4E (0.42) | SMN1; SMN2SLC9A3FBP1KDM4ECYP1A2 | |
| SCHEMBL25188877 | 0.88 | KDM4E (0.43) | SLC9A3FBP1MAOBKDM4ECXCR1 | |
| SCHEMBL25546364 | 0.87 | FBP1 (0.45) | SMN1; SMN2NPC1RAB9ASLC9A3FBP1 | |
| SCHEMBL25546356 | 0.86 | KDM4E (0.46) | SMN1; SMN2NPC1MAPTRAB9AFBP1 | |
| SCHEMBL25546355 | 0.85 | FBP1 (0.42) | SMN1; SMN2SLC9A3FBP1KDM4ECXCR1 | |
| SCHEMBL25546513 | 0.85 | SMN1; SMN2 (0.47) | SMN1; SMN2FBP1KDM4ECYP1A2CYP19A1 | |
| SCHEMBL25546032 | 0.83 | KMT2A (0.47) | SMN1; SMN2NPC1MAPTRAB9AFBP1 | |
| SCHEMBL25545933 | 0.81 | TDP1 (0.44) | SMN1; SMN2NPC1MAPTRAB9AFBP1 | |
| SCHEMBL25546361 | 0.80 | FBP1 (0.43) | MAPTFBP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103368-A | EIF4E inhibitors and uses thereof | 皮克医疗公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20230150997-A1 | EIF4E INHIBITORS AND USES THEREOF | PIC Therapeutics, Inc. | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150997-A1 | EIF4E INHIBITORS AND USES THEREOF | EIF4E, EIF4EBP1, EIF4A1 | SMN1; SMN2 2186/4885NPC1 2317/4885MAPT 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.